Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved”

The research leading to these results was mainly funded by the European Commission under the 7th framework program of the European Union (grant agreement number 211696). Additional funding was provided by the EU Joint Programs – Neurodegenerative Disease Research (EU-FINGERS and Multi-MeMo grants; BMBF 01ED1509 and BMBF 03ED2306); and European Research Council (804371). These funders had no role in the design and conduct of the study; in the collection, analysis, and interpretation of data; in the preparation of the manuscript; or in the review or approval of the manuscript. The LipiDiDiet consortium received funding by Danone Nutricia Research for the intervention period from 25 to 96 months and the consortium distributed the funding to their members to conduct the trial and analysis.